Note: Ingredients listed on restricted chemical lists
EC/CAS
212-782-2/868-77-9
Name of the chemical
2-hydroxyethyl methacrylate
Concentration
10-20% 5-<10%
EC/CAS
210-199-8/79-41-4
Name of the chemical
methacrylic acid
Concentration
0,1-<1%
EC/CAS
204-977-6/609-72-3
Name of the chemical
N,N'-dimethyl-o-toluidine
Concentration
N/A
General Information
Revision date
2017-04-25
Product name
LOCTITE 609 RETAINING COMPOUND known as LOCTITE 609 RETAINING COMPOU
1.2.1 Relevant identified uses
Adhesive
Emergency telephone
+49-(0)211-797-3350
Icons in SDS
Company Information
company name
Henkel AG & Co. KGaA
e-mail address of the competent person responsible for the Safety Data Sheet
ua-productsafety.de@henkel.com
GHS Information
Signal word
Warning
Hazard Codes
Hazard statements (CLP)
H315, H317, H319, H335
Hazard statements
Code
Statements
H315
Causes skin irritation
Section 2
SECTION 2: Hazards identification
Classification (CLP) Classification of the substance or mixture
2.2 Label elements
(CLP)
Signal word
Warning
Hazard statements
H315 Causes skin irritation. H317 May cause an allergic skin reaction. H319 Causes serious eye irritation. H335 May cause respiratory irritation.
Precautionary statements
P261 Avoid breathing vapours. P302+P352 IF ON SKIN: Wash with plenty of soap and water.
Prevention
P280 Wear protective gloves.
Response
P333+P313 If skin irritation or rash occurs: Get medical advice/attention. P337+P313 If eye irritation persists: Get medical advice/attention.
Other hazards
None if used properly. Not fulfilling Persistent, Bioaccumulative and Toxic (PBT), very Persistent and very Bioaccumulative (vPvB) criteria
2.1 Classification of the substance or mixture
Classification (CLP): Skin irritation Category 2 H315 Causes skin irritation. Serious eye irritation Category 2 H319 Causes serious eye irritation. Skin sensitizer Category 1 H317 May cause an allergic skin reaction. Specific target organ toxicity - single exposure Category 3 H335 May cause respiratory irritation. Target organ: respiratory tract irritation
